<DOC>
	<DOC>NCT01002625</DOC>
	<brief_summary>PF-04457845 has been shown to temporarily decrease the dream (REM) period of sleep in rats, which suggests that PF-04457845 is active in rat's brains. This study is designed to see whether this is also the case in man.</brief_summary>
	<brief_title>A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers</brief_title>
	<detailed_description>The trial was terminated prematurely December 3, 2009 owing to an operational error. There were no safety or efficacy concerns relating to the study and the decision to terminate the trial.</detailed_description>
	<criteria>Healthy male subjects between the ages of 18 and 55 years Body Mass Index (BMI) between 17.5 and 30.5 kg/m2; and a total body weight &gt;50 kg History of any active sleep disorder. History of any sleep or circadian rhythm sleep disorder including RLS, narcolepsy, sleep apnea, phase advance or delay syndromes within the past 5 years. Currently on or planning to be involved in night or rotating shift work or traveling across more than four time zones in 14 days prior to screening.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints</keyword>
</DOC>